AtaiBeckley vs Degron Therapeutics
AtaiBeckley vs Degron Therapeutics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AtaiBeckley is on 56/100 and Degron Therapeutics on 62/100.
Where each one leads
AtaiBeckley
- agent readiness: 41/100 against 27/100
- domain rating: 54/100 against 24/100
- headcount: 95 against 24
- funding raised: $640M against $40.0M
- LinkedIn following: 33,137 against 1,380
Degron Therapeutics
- our overall score: 62/100 against 56/100
At a glance
| Measure | AtaiBeckley | Degron Therapeutics |
|---|---|---|
| What it is | A clinical-stage biopharmaceutical company developing psychedelic-based therapies for mental health disorders. | Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. |
| Category | Biotech & Life Sciences, MedTech, HealthTech, Drug Discovery | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2018 | 2020 |
| Headquarters | New York, United States | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | AtaiBeckley | Degron Therapeutics |
|---|---|---|
| Employees | 95 | 24 |
| Total funding | $640M | $40.0M |
| Latest round | Merger | Series A Extension |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 33,137 | 1,380 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AtaiBeckley | Degron Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 62/100 |
| Traction | 60/100 | Not published |
| Team | 30/100 | 24/100 |
| Search visibility | 28/100 | 57/100 |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (41/100) | F (27/100) |
| Domain ratingLink authority, 0-100 | 54/100 | 24/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | AtaiBeckley | Degron Therapeutics |
|---|---|---|
| Hosting | Vercel | Self Managed |
| CDN | Vercel | Not detected |
| Frameworks | Next.js, Tailwind CSS | Not detected |
AtaiBeckley vs Degron Therapeutics: common questions
Which is better, AtaiBeckley or Degron Therapeutics?
On our 0-100 score Degron Therapeutics rates higher (62/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do AtaiBeckley and Degron Therapeutics compare on the numbers?
AtaiBeckley leads on agent readiness (41/100 against 27/100), domain rating (54/100 against 24/100), headcount (95 against 24), funding raised ($640M against $40.0M), LinkedIn following (33,137 against 1,380). Degron Therapeutics leads on our overall score (62/100 against 56/100).
Read the full AtaiBeckley review and pricing or the Degron Therapeutics review and pricing. You can also browse other AtaiBeckley alternatives we track.